Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionSowell Financial Services LLC
Latest Disclosed Ownership7,353 shares
Latest Disclosed Value $ 1,123,205
Sowell Financial Services LLC reports 1.90% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 20, 2026 - Sowell Financial Services LLC filed a 13F-HR form disclosing ownership of 7,353 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $944,860 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 7,216 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 1.90% during the quarter. The current value of the position is $889,713 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,353 137 1.90 1,123 12.98 0.0415
2026-01-21 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,216 645 9.82 995 18.05 0.0365
2025-10-17 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,571 -116 -1.73 843 4.08 0.0323
2025-07-14 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,687 206 3.18 809 12.05 0.0330
2025-04-17 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,481 6,481 722 0.0329
2025-02-07 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -10,386 -100.00 0 -100.00
2024-10-04 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 10,386 10,386 1,195 0.0555
2023-08-14 2023-06-30 13F NOVARTIS ADR 66987V109 0 -2,606 -100.00 0 0.0000
2023-05-12 2023-03-31 13F NOVARTIS ADR 66987V109 2,606 2,606 0 0.0185
2021-08-05 2021-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 0 -3,913 -100.00 0 -100.00
2021-05-07 2021-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 3,913 -266 -6.37 342 -13.42 0.0119
2021-01-13 2020-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 4,179 23 0.55 395 9.42 0.0169
2020-11-12 2020-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 4,156 -67 -1.59 361 -2.17 0.0180
2020-08-13 2020-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 4,223 192 4.76 369 11.14 0.0203
2020-05-12 2020-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 4,031 -407 -9.17 332 -20.95 0.0246
2020-02-07 2019-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 4,438 129 2.99 420 12.30 0.0320
2019-11-14 2019-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 4,309 -115 -2.60 374 -12.00 0.0309
2019-05-15 2019-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 4,424 103 2.38 425 14.56 0.0474
2019-03-05 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 4,321 348 8.76 371 8.48 0.0525
2018-11-13 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,973 285 7.73 342 12.50 0.0496
2018-08-14 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,688 147 4.15 304 13.43 0.0645
2018-05-10 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,541 -215 -5.72 268 -17.54 0.0670
2018-01-29 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,756 330 9.63 325 14.44 0.0795
2017-11-07 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,426 68 2.03 284 0.35 0.0740
2017-08-14 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,358 0 0.00 283 3.66 0.0803
2017-05-31 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,358 1,822 118.62 273 135.34 0.0806
2017-02-27 2016-12-31 13F Novartis AG ADR SPONSORED ADR 66987V109 1,536 1,536 116 0.0388
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.